PUBLISHER: Grand View Research | PRODUCT CODE: 2040484
PUBLISHER: Grand View Research | PRODUCT CODE: 2040484
The global aesthetic medicine market size was estimated at USD 98.8 billion in 2025 and is projected to reach USD 240.0 billion by 2033, growing at a CAGR of 11.9% from 2026 to 2033. This growth can be attributed to the increasing adoption of minimally invasive and noninvasive procedures, coupled with growth in the population prone to experiencing signs of aging.
As per the ISAPS report, approximately 17.42 million surgical procedures and 20.54 million non-surgical procedures were performed in 2025. Moreover, technological advancements, such as minimally invasive techniques, laser treatments, and injectables such as Botox and dermal fillers, have made cosmetic procedures safer and more accessible, encouraging more individuals to consider them.
In addition, the growth of healthcare tourism and the availability of well-trained specialists in emerging markets support the expansion of this market. The section below outlines the key factors driving the growth of aesthetic medicines, highlighting the rising demand for minimally invasive procedures, a growing generic population, and the rising use of aesthetic medicines by men due to changing beauty standards. It also examines the role of social media platforms in changing and idealizing beauty standards.
Rising Demand for Minimally Invasive Procedures
The market is driven by the increasing popularity of minimally invasive, non-surgical options such as botulinum toxin injections, dermal fillers, and laser treatments. Consumers opt for these procedures as they offer benefits such as shorter recovery times, lower risks, lower costs, and faster healing than traditional surgeries. Ongoing improvements in device technology and injectable products have also increased the safety and effectiveness of these treatments. In November 2025, Allergan Aesthetics showcased clinical data and expanded indications for BOTOX Cosmetic and hyaluronic acid dermal fillers at the American Society for Dermatologic Surgery (ASDS) Annual Meeting. The data highlighted high patient satisfaction and safety, as well as growing adoption of non-surgical injectable treatments.
Growing Geriatric Population Driving Demand for Anti-Aging Aesthetic Treatments
The increasing geriatric population across the globe is expected to drive the market. Major economies are undergoing a demographic shift due to a rapidly aging population, and the demand for cosmetic solutions is growing to combat the visible signs of aging and maintain a youthful appearance. This has led to a significant surge in demand for aesthetic medicines that effectively reduce wrinkles, fine lines, and other age-related concerns. In November 2025, Galderma presented data on a range of pioneering Restylane hyaluronic acid (HA) injectables, Restylane Lyft, Restylane Contour, and Restylane Skinboosters, which highlighted that these treatments effectively improved facial wrinkles, loss of firmness, and contour deficiencies associated with aging-related volume loss, with high patient satisfaction and sustained results.
Global Aesthetic Medicine Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global aesthetic medicine market report based on procedure, end use, and region: